The Prudential Regulation Authority stated on 29 April 2026 that protected cell company captives would not be included in the initial launch of the UK’s new captive regime, then expected in summer 2027. Legislative changes needed for PCCs to operate as insurers would not be ready in time for the planned consultation or launch.

The PRA intended to consult on incorporating PCCs once legislation was in place. It describes PCCs as a potentially more affordable route for smaller organisations and a pilot option before a standalone captive. These are April expectations, not confirmation of a subsequent implementation outcome.

Separate the contemplated routes This editor recommends distinguishing the proposed UK standalone route from future PCC access. A business case should identify the structure assumed, the permissions required and the timetable on which the analysis depends. Explicit assumptions prevent a general market announcement from becoming an unexamined project milestone. The team should be able to explain which part of its proposal depends on a development that has yet to occur.

For benefits risk financing, ask whether the arrangement can accommodate the specific risks under consideration. A domicile timetable does not answer questions about policy eligibility, insurer participation or the organisation’s obligations. Those questions require analysis of the contemplated structure and relevant jurisdictions. The benefits team should therefore participate in the review alongside insurance and financial advisers.

Use documented decision points This editor recommends maintaining a list of official developments that would allow the project to advance. These may concern consultation proposals, final rules, legislation and application processes. Each should have a named reviewer and a documented effect on the business case. The organisation can revise its assumptions when evidence changes and make clear which decisions remain conditional.

Alternatives should be compared consistently. Access costs, governance, retained exposure and operating requirements belong beside the expected timetable. A prospective advantage should remain an assumption until supporting terms and processes are established. The organisation should record what further evidence would be needed to select an option rather than presenting an incomplete comparison as a finished recommendation.

The April statement is material to planning: PCC access cannot be treated as part of the initial launch assumption described then. A disciplined review preserves that distinction and updates the project as official information becomes available, with responsibility for monitoring developments assigned in advance.

Sources: Source de référence